Effects of Mesalamine Combined with Live Combined Bifidobacterium, Lactobacillus and Enterococcus Capsules on Intestinal Mucosa Barrier Function and Intestinal Microbiota in Mildly Active Crohn’s Disease Patients
Meiqin Shen, Yingqi Shi, Zhenming Ge, Qian Junbo
Abstract
Mesalamine combined with Live combined Bifidobacterium, Lactobacillus and Enterococcus capsules are more effective in treating mildly active Crohn's disease.
Topics & Concepts
BifidobacteriumMedicineBarrier functionLactobacillusCrohn's diseaseIntestinal mucosaBifidobacterium longumEnterococcusProbioticGastroenterologyMicrobiomeInflammatory bowel diseaseMicrobiologyDiseaseInternal medicineBacteriaBioinformaticsAntibioticsBiologyCell biologyGeneticsInflammatory Bowel DiseaseGut microbiota and healthGastrointestinal motility and disorders